AAMDSIF Research Grants Program supports new investigators studying aplastic anemia, MDS, and PNH through research aimed at improving understanding, treatment, and outcomes in bone marrow failure disorders.
Funder: Aplastic Anemia & MDS International Foundation
Due Dates: June 30, 2026 (letter of intent) | October 31, 2026 (invited applications)
Funding Amounts: $80,000 per project over two years ($40,000 per year); three projects funded
Summary: Supports new investigators researching aplastic anemia, MDS, or PNH to advance understanding and treatment of bone marrow failure disorders.
Key Information: Full applications are by invitation following review of a required letter of intent.
The Aplastic Anemia & MDS International Foundation (AAMDSIF) funds new investigators studying bone marrow failure disorders in pediatric and adult populations. The 2026 program supports projects focused on aplastic anemia, myelodysplastic syndromes or neoplasms (MDS), or paroxysmal nocturnal hemoglobinuria (PNH), with one award reserved for aplastic anemia research.
The program accepts basic, translational, pre-clinical, early-stage clinical, and health services or epidemiological research. AAMDSIF seeks work with promising clinical impact, including studies of disease mechanisms, treatment, and patient outcomes. Its Medical Advisory Board reviews proposals for scientific merit and relevance to the foundation’s goals.